First vendor for RADIAL proof-of-concept-study contracted

Utrecht, December 22, 2021

As discussed in our latest webinar, we have selected the full tech package for the RADIAL study and are now contracting the selected vendors. We are excited to announce that the first vendor has been contracted: Signant Health

Read the press release from Signant Health here: https://www.prnewswire.com/news-releases/trialshome-consortium-selects-signant-health-for-high-profile-research-project-to-develop-recommendations-that-will-drive-the-implementation-of-decentralized-clinical-trials-in-europe-301463071.html 

IMI
EFPIA
EU

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831458. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Notes for editors – not for publication
If you would like more information, please contact the spokesperson at the UMC Utrecht.
Joris Prinssen: +31 6 2571 0234
press@umcutrecht.nl